Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Collegium Pharmaceutical (COLL) over the last 6 years, with Q3 2025 value amounting to $222.5 million.

  • Collegium Pharmaceutical's Treasury Shares rose 2908.04% to $222.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $222.5 million, marking a year-over-year increase of 2908.04%. This contributed to the annual value of $197.5 million for FY2024, which is 4376.44% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Treasury Shares stood at $9.0 million for Q3 2025, which was up 2223.37% from $8.9 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Treasury Shares peaked at $9.0 million during Q3 2025, and registered a low of -$859040.0 during Q3 2021.
  • Its 5-year average for Treasury Shares is $4.7 million, with a median of $3.2 million in 2022.
  • Its Treasury Shares has fluctuated over the past 5 years, first skyrocketed by 21054.35% in 2022, then surged by 2908.04% in 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Treasury Shares (Quarter) stood at $42.9 million in 2021, then skyrocketed by 44.48% to $61.9 million in 2022, then skyrocketed by 121.85% to $137.4 million in 2023, then surged by 43.76% to $197.5 million in 2024, then rose by 12.66% to $222.5 million in 2025.
  • Its Treasury Shares was $222.5 million in Q3 2025, compared to $217.5 million in Q2 2025 and $197.5 million in Q1 2025.